Patent · US Active

Aminoquinoline derivatives and uses thereof

US9567316B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 28, 2013
Grant dateFeb 14, 2017
Priority date
Expiry dateFeb 28, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are aminoquinoline and aminoacridine based hybrids, pharmaceutical compositions and medicaments that include such aminoquinoline and aminoacridine based hybrids, and methods of using such compounds for diagnosing and/or treating infections, neurodegerative diseases or disorders, inflammation, inflammation associated diseases and disorders, and/or diseases or disorders that are treatable with dopamine agonists such as the restless leg syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.